1. Home
  2. NRXP vs JELD Comparison

NRXP vs JELD Comparison

Compare NRXP & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NRX Pharmaceuticals Inc.

NRXP

NRX Pharmaceuticals Inc.

N/A

Current Price

$3.47

Market Cap

151.1M

Sector

Health Care

ML Signal

N/A

Logo JELD-WEN Holding Inc.

JELD

JELD-WEN Holding Inc.

N/A

Current Price

$2.19

Market Cap

152.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
NRXP
JELD
Founded
2015
1960
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Forest Products
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
151.1M
152.5M
IPO Year
2017
2016

Fundamental Metrics

Financial Performance
Metric
NRXP
JELD
Price
$3.47
$2.19
Analyst Decision
Strong Buy
Hold
Analyst Count
4
6
Target Price
$38.25
$3.43
AVG Volume (30 Days)
790.1K
1.7M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
69.70
N/A
EPS
N/A
N/A
Revenue
$1,225,000.00
$3,211,181,000.00
Revenue This Year
$2,547.84
N/A
Revenue Next Year
$1,591.73
$2.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.65
$0.93
52 Week High
$5.06
$6.51

Technical Indicators

Market Signals
Indicator
NRXP
JELD
Relative Strength Index (RSI) 49.32 54.83
Support Level $3.45 $1.10
Resistance Level $3.62 $3.12
Average True Range (ATR) 0.17 0.22
MACD 0.02 -0.03
Stochastic Oscillator 46.67 46.75

Price Performance

Historical Comparison
NRXP
JELD

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.

Share on Social Networks: